Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries SHAREHOLDER ALERT: NNOX FB SBTX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines By: The Law Offices of Vincent Wong via AccessWire November 18, 2021 at 16:00 PM EST NEW YORK, NY / ACCESSWIRE / November 18, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.Nano-X Imaging Ltd. (NASDAQ:NNOX)If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/nano-x-imaging-ltd-loss-submission-form-2?prid=21374&wire=1Lead Plaintiff Deadline: December 6, 2021Class Period: June 17, 2021 - August 18, 2021Allegations against NNOX include that: (i) Nano-X's 510(k) application for the Nanox.ARC was deficient; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the 510(k) application for the Nanox.ARC in its current form; (iii) as a result, NanoX had overstated the Nanox.ARC's regulatory and commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.Meta Platforms, Inc. f.k.a. Facebook, Inc. (NASDAQ:FB)If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/facebook-inc-loss-submission-form?prid=21374&wire=1Lead Plaintiff Deadline: December 27, 2021Class Period: November 3, 2016 - October 21, 2021Allegations against FB include that: (1) Facebook misrepresented its user growth; (2) Facebook knew, or should have known, that duplicate accounts represented a greater portion of its growth than stated, and it should have provided more detailed disclosures as to the implication of duplicate accounts to Facebook's user base and growth; (3) Facebook did not provide a fair platform for speech, and regularly protected high profile users via its Cross Check/XCheck system; (4) despite being aware of their use of Facebook's platforms, the Company failed to respond meaningfully to drug cartels, human traffickers, and violent organizations; (5) Facebook has been working to attract preteens to its platform and services; and (6) as a result, Defendants' public statements were materially false and misleading at all relevant times.Silverback Therapeutics, Inc. (NASDAQ:SBTX)If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/silverback-therapeutics-inc-loss-submission-form?prid=21374&wire=1Lead Plaintiff Deadline: January 4, 2022This lawsuit is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Silverback common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about December 3, 2020 and/or (b) Silverback securities between December 3, 2020 and September 10, 2021, both dates inclusive.Allegations against SBTX include that: (i) Silverback's lead product candidate SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers, was less effective than the Company had represented to investors; (ii) accordingly, the Company had overstated SBT6050's commercial and/or clinical prospects; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:Vincent Wong, Esq.39 East BroadwaySuite 304New York, NY 10002Tel. 212.425.1140Fax. 866.699.3880E-Mail: vw@wongesq.comSOURCE: The Law Offices of Vincent WongView source version on accesswire.com: https://www.accesswire.com/673693/SHAREHOLDER-ALERT-NNOX-FB-SBTX-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
SHAREHOLDER ALERT: NNOX FB SBTX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines By: The Law Offices of Vincent Wong via AccessWire November 18, 2021 at 16:00 PM EST NEW YORK, NY / ACCESSWIRE / November 18, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.Nano-X Imaging Ltd. (NASDAQ:NNOX)If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/nano-x-imaging-ltd-loss-submission-form-2?prid=21374&wire=1Lead Plaintiff Deadline: December 6, 2021Class Period: June 17, 2021 - August 18, 2021Allegations against NNOX include that: (i) Nano-X's 510(k) application for the Nanox.ARC was deficient; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the 510(k) application for the Nanox.ARC in its current form; (iii) as a result, NanoX had overstated the Nanox.ARC's regulatory and commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.Meta Platforms, Inc. f.k.a. Facebook, Inc. (NASDAQ:FB)If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/facebook-inc-loss-submission-form?prid=21374&wire=1Lead Plaintiff Deadline: December 27, 2021Class Period: November 3, 2016 - October 21, 2021Allegations against FB include that: (1) Facebook misrepresented its user growth; (2) Facebook knew, or should have known, that duplicate accounts represented a greater portion of its growth than stated, and it should have provided more detailed disclosures as to the implication of duplicate accounts to Facebook's user base and growth; (3) Facebook did not provide a fair platform for speech, and regularly protected high profile users via its Cross Check/XCheck system; (4) despite being aware of their use of Facebook's platforms, the Company failed to respond meaningfully to drug cartels, human traffickers, and violent organizations; (5) Facebook has been working to attract preteens to its platform and services; and (6) as a result, Defendants' public statements were materially false and misleading at all relevant times.Silverback Therapeutics, Inc. (NASDAQ:SBTX)If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/silverback-therapeutics-inc-loss-submission-form?prid=21374&wire=1Lead Plaintiff Deadline: January 4, 2022This lawsuit is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Silverback common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about December 3, 2020 and/or (b) Silverback securities between December 3, 2020 and September 10, 2021, both dates inclusive.Allegations against SBTX include that: (i) Silverback's lead product candidate SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers, was less effective than the Company had represented to investors; (ii) accordingly, the Company had overstated SBT6050's commercial and/or clinical prospects; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:Vincent Wong, Esq.39 East BroadwaySuite 304New York, NY 10002Tel. 212.425.1140Fax. 866.699.3880E-Mail: vw@wongesq.comSOURCE: The Law Offices of Vincent WongView source version on accesswire.com: https://www.accesswire.com/673693/SHAREHOLDER-ALERT-NNOX-FB-SBTX-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines